146 related articles for article (PubMed ID: 27110565)
1. Prenatal Evaluation of MicroRNA Expressions in Pregnancies with Down Syndrome.
Erturk B; Karaca E; Aykut A; Durmaz B; Guler A; Buke B; Yeniel AO; Ergenoglu AM; Ozkinay F; Ozeren M; Kazandi M; Akercan F; Sagol S; Gunduz C; Cogulu O
Biomed Res Int; 2016; 2016():5312674. PubMed ID: 27110565
[TBL] [Abstract][Full Text] [Related]
2. Extracellular chromosome 21-derived microRNAs in euploid & aneuploid pregnancies.
Kotlabova K; Doucha J; Chudoba D; Calda P; Dlouha K; Hromadnikova I
Indian J Med Res; 2013 Dec; 138(6):935-43. PubMed ID: 24521639
[TBL] [Abstract][Full Text] [Related]
3. [Extracellular chromosome 21--derived microRNAs in maternal circulation: evaluation of their diagnostic potential for screening of Down syndrome].
Hromadníková I; Kotlabová K; Doucha J; Chudoba D; Calda P; Dlouhá K
Ceska Gynekol; 2012 Oct; 77(5):395-402. PubMed ID: 23116342
[TBL] [Abstract][Full Text] [Related]
4. MicroRNA Expression Profile in the Prenatal Amniotic Fluid Samples of Pregnant Women with Down Syndrome.
Karaca E; Aykut A; Ertürk B; Durmaz B; Güler A; Büke B; Yeniel AÖ; Ergenoğlu AM; Özkınay F; Özeren M; Kazandı M; Akercan F; Sağol S; Gündüz C; Çoğulu Ö
Balkan Med J; 2018 Mar; 35(2):163-166. PubMed ID: 29219113
[TBL] [Abstract][Full Text] [Related]
5. [Value of detection of cell-free fetal DNA in maternal plasma in the prenatal diagnosis of chromosomal abnormalities].
Wang SJ; Gao ZY; Lu YP; Li YL; You YQ; Zhang LW; Wang LX; Xu H
Zhonghua Fu Chan Ke Za Zhi; 2012 Nov; 47(11):808-12. PubMed ID: 23302119
[TBL] [Abstract][Full Text] [Related]
6. Only a minority of sex chromosome abnormalities are detected by a national prenatal screening program for Down syndrome.
Viuff MH; Stochholm K; Uldbjerg N; Nielsen BB; ; Gravholt CH
Hum Reprod; 2015 Oct; 30(10):2419-26. PubMed ID: 26251461
[TBL] [Abstract][Full Text] [Related]
7. Circulating MicroRNAs in the Screening of Prenatal Down Syndrome.
Balci S; Cayan F; Dogru Ozdemir G; Ay ME; Yildirim DD; Tamer L
P R Health Sci J; 2023 Sep; 42(3):219-225. PubMed ID: 37709679
[TBL] [Abstract][Full Text] [Related]
8. Mature miR-99a Upregulation in the Amniotic Fluid Samples from Female Fetus Down Syndrome Pregnancies: A Pilot Study.
Vizitiu AC; Stambouli D; Pavel AG; Muresan MC; Anastasiu DM; Bejinar C; Alexa A; Marian C; Sirbu IO; Sima L
Medicina (Kaunas); 2019 Nov; 55(11):. PubMed ID: 31703316
[No Abstract] [Full Text] [Related]
9. Down Syndrome: what do pregnant women know about their individual risk? A prospective trial.
Strauss A; Heer IM; Spelsberg F; Strauss C
Arch Gynecol Obstet; 2013 Jun; 287(6):1119-23. PubMed ID: 23334105
[TBL] [Abstract][Full Text] [Related]
10. Periodic health examination, 1996 update: 1. Prenatal screening for and diagnosis of Down syndrome. Canadian Task Force on the Periodic Health Examination.
Dick PT
CMAJ; 1996 Feb; 154(4):465-79. PubMed ID: 8630836
[TBL] [Abstract][Full Text] [Related]
11. [Study on key techniques and intervention in reducing birth defects].
Zhu BS; Su J; Lu XH; He J; Zhu S; Jiao CX; Zhang JM; Tang XH; Tao Y; Lin KP; Chen H; Li SY
Zhonghua Fu Chan Ke Za Zhi; 2011 Sep; 46(9):658-63. PubMed ID: 22176989
[TBL] [Abstract][Full Text] [Related]
12. [Non-invasive genetic tests for fetal trisomy 21 detection: current considerations].
Benachi A; Costa JM
J Gynecol Obstet Biol Reprod (Paris); 2014 Mar; 43(3):195-7. PubMed ID: 24529921
[No Abstract] [Full Text] [Related]
13. Effectiveness of combining maternal serum alpha-fetoprotein and hCG in a second-trimester screening program for Down syndrome.
Mooney RA; Peterson CJ; French CA; Saller DN; Arvan DA
Obstet Gynecol; 1994 Aug; 84(2):298-303. PubMed ID: 7518896
[TBL] [Abstract][Full Text] [Related]
14. Genome-wide miRNA profiling in plasma of pregnant women with down syndrome fetuses.
Zedníková I; Chylíková B; Šeda O; Korabečná M; Pazourková E; Břešťák M; Krkavcová M; Calda P; Hořínek A
Mol Biol Rep; 2020 Jun; 47(6):4531-4540. PubMed ID: 32472298
[TBL] [Abstract][Full Text] [Related]
15. Complete trisomy 21 vs translocation Down syndrome: a comparison of modes of ascertainment.
Bornstein E; Lenchner E; Donnenfeld A; Jodicke C; Keeler SM; Kapp S; Divon MY
Am J Obstet Gynecol; 2010 Oct; 203(4):391.e1-5. PubMed ID: 20691415
[TBL] [Abstract][Full Text] [Related]
16. Quantitative real-time PCR technique for rapid prenatal diagnosis of Down syndrome.
Hu Y; Zheng M; Xu Z; Wang X; Cui H
Prenat Diagn; 2004 Sep; 24(9):704-7. PubMed ID: 15386450
[TBL] [Abstract][Full Text] [Related]
17. [Clinical application of noninvasive prenatal diagnosis using cell free fetal DNA in maternal plasma].
Hou QF; Wu D; Chu Y; Kang B; Liao SX; Yang YL; Zhang CY; Zhang JX; Wu G
Zhonghua Fu Chan Ke Za Zhi; 2012 Nov; 47(11):813-7. PubMed ID: 23302120
[TBL] [Abstract][Full Text] [Related]
18. Prenatal genetic diagnosis of Down's syndrome.
Abbott MA; Benn P
Expert Rev Mol Diagn; 2002 Nov; 2(6):605-15. PubMed ID: 12465456
[TBL] [Abstract][Full Text] [Related]
19. Maternal serum biochemistry at 11-13(+6) weeks in relation to the presence or absence of the fetal nasal bone on ultrasonography in chromosomally abnormal fetuses: an updated analysis of integrated ultrasound and biochemical screening.
Cicero S; Spencer K; Avgidou K; Faiola S; Nicolaides KH
Prenat Diagn; 2005 Nov; 25(11):977-83. PubMed ID: 16245371
[TBL] [Abstract][Full Text] [Related]
20. Thickened nuchal fold in fetuses not at risk for aneuploidy.
Benacerraf BR; Laboda LA; Frigoletto FD
Radiology; 1992 Jul; 184(1):239-42. PubMed ID: 1535162
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
